Descripción

Oxandrolone by Genpharma is an advanced oral formulation featuring superior metabolic tolerance, indicated for lean muscle tissue preservation during caloric deficit phases and net strength enhancement without unwanted body weight accumulation.

Delivered in pharmaceutical-grade oral tablets, this DHT-derived compound does not convert to estrogen, eliminating the risk of water retention and gynecomastia while delivering a dense, dry, and vascular physical conditioning under guidance.

1. General Information

• Brand Name: Oxandrolona Genpharma.
• Active Ingredient: Oxandrolone.
• Concentration: 10 mg / tablet (or 50 mg depending on batch/presentation).
• Presentation: Oral tablet bottle / blister pack.
• Route of Administration: Oral route.

2. Composition

Each tablet contains:

• Oxandrolone: 10 mg (or 50 mg).
• Excipientes: Lactose monohydrate, corn starch, microcrystalline cellulose, magnesium stearate, and colloidal silicon dioxide.

3. Pharmacological Properties & Benefits

• No Estrogenic Conversion: Zero estrogenic conversion, entirely preventing subcutaneous fluid retention and ensuring a sharp, defined muscular appearance.
• Enhanced Phosphocreatine Synthesis & Strength: Stimulates muscular phosphocreatine synthesis, boosting peak strength and explosive power without added body weight.
• Lean Tissue Preservation: Effectively protects lean tissue against catabolism induced by strict calorie-restricted diets.
• Low Hepatotoxicity & Mild Profile: Features the lowest hepatic toxicity rating among oral C17-alpha alkylated compounds, guaranteeing high metabolic tolerance.

4. Reconstitution & Storage

• Reconstitution: Ready-to-use oral tablets; no mixing required.
• Storage Temperature: Store at controlled room temperature between 15°C and 25°C (59°F to 77°F).
• Protection: Protect from direct sunlight, excess humidity, and heat. Store in original container tightly closed.

5. Warnings & Safety

• Prescription Only: For professional or medically supervised use only.
• Contraindications: Contraindicated in individuals with prostate or male breast carcinoma, hypercalcemia, or severe hepatic impairment. Strictly contraindicated during pregnancy or lactation.
• Regular Monitoring: Despite its low toxicity profile, routine monitoring of liver enzymes (ALT/AST) and lipid profiles (HDL/LDL) is recommended during prolonged use.
• Side Effects: Possible mild alterations in blood lipid levels and minor HPTA axis suppression at higher dosages.
• Child Safety: Keep out of reach of children.